Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

BACKGROUND: EGFR-positive Non-small Cell Lung Cancer (NSCLC) is a dynamic entity and tumor progression and resistance to tyrosine kinase inhibitors (TKIs) arise from the accumulation, over time and across different disease sites, of subclonal genetic mutations. For instance, the occurrence of EGFR T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Cucchiara, Federico, Del Re, Marzia, Valleggi, Simona, Romei, Chiara, Petrini, Iacopo, Lucchesi, Maurizio, Crucitta, Stefania, Rofi, Eleonora, De Liperi, Annalisa, Chella, Antonio, Russo, Antonio, Danesi, Romano
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819134/
https://ncbi.nlm.nih.gov/pubmed/33489892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.593831
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller